105 related articles for article (PubMed ID: 9815748)
1. K252a inhibits proliferation of glioma cells by blocking platelet-derived growth factor signal transduction.
Chin LS; Murray SF; Zitnay KM; Rami B
Clin Cancer Res; 1997 May; 3(5):771-6. PubMed ID: 9815748
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
[TBL] [Abstract][Full Text] [Related]
3. K252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors.
Tapley P; Lamballe F; Barbacid M
Oncogene; 1992 Feb; 7(2):371-81. PubMed ID: 1312698
[TBL] [Abstract][Full Text] [Related]
4. An abnormal response of retinoblastoma cells (Y-79) to neurotrophins.
Wagner N; Wagner KD; Sefton M; Rodríguez-Tébar A; Grantyn R
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1932-9. PubMed ID: 10845619
[TBL] [Abstract][Full Text] [Related]
5. Anti-proliferative effect of the kinase inhibitor K252a on human prostatic carcinoma cell lines.
Delsite R; Djakiew D
J Androl; 1996; 17(5):481-90. PubMed ID: 8957691
[TBL] [Abstract][Full Text] [Related]
6. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells.
Lee LT; Huang YT; Hwang JJ; Lee PP; Ke FC; Nair MP; Kanadaswam C; Lee MT
Anticancer Res; 2002; 22(3):1615-27. PubMed ID: 12168845
[TBL] [Abstract][Full Text] [Related]
7. Neurotrophic factors in the human cornea.
You L; Kruse FE; Völcker HE
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):692-702. PubMed ID: 10711683
[TBL] [Abstract][Full Text] [Related]
8. Platelet-derived growth factor in human glioma.
Westermark B; Heldin CH; Nistér M
Glia; 1995 Nov; 15(3):257-63. PubMed ID: 8586462
[TBL] [Abstract][Full Text] [Related]
9. Effect of exogenous neurotrophins on Trk receptor phosphorylation, cell proliferation, and neurotrophin secretion by cells isolated from the human lamina cribrosa.
Lambert WS; Clark AF; Wordinger RJ
Mol Vis; 2004 Apr; 10():289-96. PubMed ID: 15105791
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of imatinib and synergism of combination treatment with chemotherapeutic agents in malignant glioma cells.
Ren H; Tan X; Dong Y; Giese A; Chou TC; Rainov N; Yang B
Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):241-52. PubMed ID: 19159435
[TBL] [Abstract][Full Text] [Related]
11. Autocrine regulation of nerve growth factor expression by Trk receptors.
Mallei A; Rabin SJ; Mocchetti I
J Neurochem; 2004 Sep; 90(5):1085-93. PubMed ID: 15312164
[TBL] [Abstract][Full Text] [Related]
12. Neurotrophin receptor expression in human primary retinoblastomas and retinoblastoma cell lines.
Stephan H; Zakrzewski JL; Bölöni R; Grasemann C; Lohmann DR; Eggert A
Pediatr Blood Cancer; 2008 Feb; 50(2):218-22. PubMed ID: 17973327
[TBL] [Abstract][Full Text] [Related]
13. The involvement of platelet-derived growth factor receptors and insulin-like growth factor-I receptors signaling during mineralized nodule formation by human periodontal ligament cells.
Nemoto E; Shimonishi M; Nitta Y; Shimauchi H
J Periodontal Res; 2004 Dec; 39(6):388-97. PubMed ID: 15491343
[TBL] [Abstract][Full Text] [Related]
14. Coadministration of sorafenib with rottlerin potently inhibits cell proliferation and migration in human malignant glioma cells.
Jane EP; Premkumar DR; Pollack IF
J Pharmacol Exp Ther; 2006 Dec; 319(3):1070-80. PubMed ID: 16959960
[TBL] [Abstract][Full Text] [Related]
15. Detection of NGF-receptors TrkA and p75NTR in human tumor cell lines and effect of NGF on the growth characteristic of the UT-7/EPO cell line.
Westphal G; van den Berg-Stein S; Braun K; Knoch TA; Dümmerling M; Langowski J; Debus J; Friedrich E
J Exp Clin Cancer Res; 2002 Jun; 21(2):255-67. PubMed ID: 12148587
[TBL] [Abstract][Full Text] [Related]
16. K252a inhibits the oncogenic properties of Met, the HGF receptor.
Morotti A; Mila S; Accornero P; Tagliabue E; Ponzetto C
Oncogene; 2002 Jul; 21(32):4885-93. PubMed ID: 12118367
[TBL] [Abstract][Full Text] [Related]
17. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors.
Buchdunger E; Cioffi CL; Law N; Stover D; Ohno-Jones S; Druker BJ; Lydon NB
J Pharmacol Exp Ther; 2000 Oct; 295(1):139-45. PubMed ID: 10991971
[TBL] [Abstract][Full Text] [Related]
18. NT-3-mediated TrkC receptor activation promotes proliferation and cell survival of rodent progenitor oligodendrocyte cells in vitro and in vivo.
Kumar S; Kahn MA; Dinh L; de Vellis J
J Neurosci Res; 1998 Dec; 54(6):754-65. PubMed ID: 9856859
[TBL] [Abstract][Full Text] [Related]
19. Neurotrophin and neurotrophin receptor expression by cells of the human lamina cribrosa.
Lambert W; Agarwal R; Howe W; Clark AF; Wordinger RJ
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2315-23. PubMed ID: 11527945
[TBL] [Abstract][Full Text] [Related]
20. Platelet-derived growth factor (PDGF) and glial tumorigenesis.
Shih AH; Holland EC
Cancer Lett; 2006 Feb; 232(2):139-47. PubMed ID: 16139423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
